Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alba Rubio
Hospital Infantil Universitario Niño Jesús
Principal Investigator - Alejandro Pérez Fidalgo
Hospital Clínico Universitario de Valencia
Principal Investigator - Andrés Redondo
Hospital Universitario La Paz
Principal Investigator - Antonio Casado
Hospital Clínico Universitario San Carlos
Principal Investigator - Antonio López Pousa
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Claudia Valverde
Hospital Universitari Vall d'Hebrón
Principal Investigator - Cristina Mata
Hospital General Universitario Gregorio Marañón
Principal Investigator - Emanuela Palmerini
Istituto Ortopedico Rizzoli
Principal Investigator - Enrique González
Hospital Universitario 12 de Octubre
Principal Investigator - Giovanni Grignani
Candiolo Cancer Institute - FPO, IRCCS
Principal Investigator - Irene Carrasco
Hospitales Universitarios Virgen del Rocío
Principal Investigator - Javier Martín Broto
Hospital Universitario Fundación Jiménez Díaz
Study Director - Javier Martínez Trufero
Hospital Miguel Servet
Principal Investigator - Jerónimo Martínez
Hospital Universitario Virgen de la Arrixaca
Principal Investigator - Josefina Cruz
Hospital Universitario de Canarias
Principal Investigator - Luis De Sande
Hospital Universitario de León
Principal Investigator - Roberto Diaz de Beveridge
Hospital Universitario La Fe
Principal Investigator - Sandra Strauss
University College London Hospitals
Principal Investigator - Silvia Stacchiotti
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Istituto Ortopedico Rizzoli
Bologna, Italy
- Candiolo Cancer Institute - Fpo, Irccs
Candiolo, Italy
- Istituto Nazionale Dei Tumori
Milan, Italy
- Hospital Universitario Fundación Jiménez Díaz
Madrid, Madrid, Spain
- Complejo Hospitalario Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
- Hospital Universitari Vall D'Hebrón
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario la Paz
Madrid, Spain
- Hospital Universitario Virgen del Rocío
Seville, Spain
- Hospital Universitari I Politècnic la Fe
Valencia, Spain
- Hospital Universitario Miguel Servet
Zaragoza, Spain
- University College London Hospitals Nhs Foundation Trust
London, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2017
- Primary completion
- 30 Jun 2024
- Completion
- 30 Jun 2024
- Last update posted
- 13 Aug 2024
- Registered enrollment
- 197
- Registry id
- NCT03277924
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.